Biology of Blood and Marrow Transplantation
Volume 10, Issue 4 , Pages 269-275 , April 2004

Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks

  • Karen K Ballen

      Affiliations

    • American Red Cross Cord Blood Program, Worcester, Massachusetts, USA
    • Massachusetts General Hospital, Boston, Massachusetts, USA
    • Corresponding Author InformationCorrespondence and reprint requests: Karen K. Ballen, MD, Hematology/Oncology Division, Massachusetts General Hospital, 100 Blossom St., Cox 640, Boston, MA 02114 USA
    • ,
  • Joanne Kurtzberg

      Affiliations

    • American Red Cross Cord Blood Program, Durham, North Carolina, USA
    • Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • Thomas A Lane

      Affiliations

    • American Red Cross Cord Blood Program, Portland, Oregon, USA
    • ,
  • Bruce R Lindgren

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota, USA
    • ,
  • John P Miller

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota, USA
    • American Red Cross Cord Blood Program, St. Paul, Minnesota, USA
    • ,
  • Denis Nagan

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota, USA
    • ,
  • Bruce Newman

      Affiliations

    • American Red Cross Cord Blood Program, Detroit, Michigan, USA
    • ,
  • Neil Rupp

      Affiliations

    • American Red Cross Cord Blood Program, Portland, Oregon, USA
    • American Red Cross Cord Blood Program, Arlington, Virginia, USA
    • ,
  • N.Rebecca Haley

      Affiliations

    • American Red Cross Cord Blood Program, Arlington, Virginia, USA

Received 18 August 2003 ,Accepted 10 December 2003.

References 

  1. Thomas ED, Clift RA, Fefer A, et al.  Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med. 1986;104:155–163
  2. Krivit W, Whitley CB. Bone marrow transplantation for genetic diseases. N Engl J Med. 1987;316:1085–1090
  3. Lucarelli G, Galimberti M, Polchi P, et al.  Marrow transplantation in patients with advanced thalassemia. N Engl J Med. 1987;316:1050–1055
  4. Anasetti C, Amos D, Beatty PG, et al.  Effect of HLA compatibility on engraftment of bone marrow transplants to patients with leukemia or lymphoma. N Engl J Med. 1987;197:320–325
  5. Kernan NA, Bartsch G, Ash RC, et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593–598
  6. National Marrow Donor Program Statistics, Minority Facts and Figures. 2002;
  7. Broxmeyer HE, Douglas GW, Hangoc G, et al.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828–3832
  8. Gluckman E, Broxmeyer HE, Auerbach AD, et al.  Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from a HLA identical sibling. N Engl J Med. 1989;321:1174–1178
  9. Kurtzberg J, Laughlin M, Graham ML, et al.  Placental blood as source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;353:157–166
  10. Rubinstein P, Carrier C, Scaradavou A, et al.  Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1578
  11. Locatelli F, Rocha V, Chastang C, et al.  Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999;93:3662–3671
  12. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol. 2000;28:1197–1205
  13. Wagner JE, Barker JN, DeFor TE, et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases (influence of CD 34 cell dose and HLA disparity of treatment-related mortality and survival). Blood. 2002;100:1611–1617
  14. Sanz GF, Saavedra S, Planelles D, et al.  Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood. 2001;98:2332–2338
  15. Laughlin MJ, Barker J, Bambach B, et al.  Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med. 2001;344:1815–1822
  16. Ooi J, Iseki T, Takahashi S, et al.  A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol. 2002;118:140–143
  17. Ballen KK, Wilson M, Wuu J, et al.  Bigger is better (predictors of hematopoietic potential of umbilical cord blood units). Bone Marrow Transplant. 2001;27:7–14
  18. Ballen KK, Broxmeyer HE, McCullough J, et al.  Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant. 2001;7:635–642
  19. Sirchia G, Rebulla P, Lecchi L, et al.  Implementation of a quality system (ISO 9000 series) for placental blood banking. J Hematother. 1998;7:19–35
  20. Kogler G, Callejas J, Hakenberg P, et al.  Hematopoietic transplant potential of unrelated cord blood (critical issues). J Hematother. 1995;5:105–116
  21. Wagner JE, Kurtzberg J. Banking and transplantation of unrelated donor umbilical cord blood (status of the National Heart, Lung, and Blood Institute-sponsored trial). Transfusion. 1998;38:807–809
  22. Ballen KK, Hicks J, Dharan B, et al.  Racial and ethnic composition of volunteer cord blood donors (comparison with volunteer unrelated marrow donors). Transfusion. 2002;42:1279–1284
  23. Lasky LC, Lane TA, Miller JP, et al.  In utero or ex utero cord blood collection (which is better?). Transfusion. 2002;42:1261–1267
  24. Rubinstein P, Dobrilla L, Rosenfield RE, et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92:10119–10122
  25. Keeney M, Chin-Yee I, Weir K, et al.  Single platform flow cytometric absolute CD 34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998;34:61–70
  26. Sutherland DR, Anderson L, Keeney M, et al.  The ISHAGE guidelines for CD 34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;3:213–226
  27. Armitage S, Warwick R, Fehily D, et al.  Cord blood banking in London (the first 1000 collections). Bone Marrow Transplant. 1999;24:139–145
  28. Baxter-Lowe LA, Kim Y, Carter S, et al.  Ability of minority patients to find donors from an ethnically diverse cord blood bank. Blood. 2002;100:2521a; (abstr.)
  29. Spigner C, Weaver M, Cardenas V, et al.  Organ donation and transplantation (ethnic differences in knowledge and opinion among urban high school students). Ethn Health. 2002;7:87–101
  30. Rozon-Solomon M, Burrows L. ’Tis better to receive than to give (the relative failure of the African American community to provide organs for transplantation). Mt Sinai J Med. 1999;66:273–276
  31. Daniels DE, Smith K, Parks-Thomas T, et al.  Organ and tissue donation (are minorities willing to donate?). Ann Transplant. 1998;3:22–24
  32. Moroff G, Seetharaman S, Kurtz J, et al.  Multi-laboratory evaluation of assays utilized with cord blood stem/progenitor cells. Blood. 2002;100:617a; (abstr.)
  33. Stewart SL, Swallen KC, Glaser SL, et al.  Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999;149:1063–1071
  34. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. JAMA. 2003;289:2709–2716
  35. Serna DS, Lee SJ, Zhang M, et al.  Trends in survival rates after allogeneic hematopoietic stem cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol. 2003;20:3754–3760

PII: S1083-8791(03)00524-X

doi: 10.1016/j.bbmt.2003.12.003

Biology of Blood and Marrow Transplantation
Volume 10, Issue 4 , Pages 269-275 , April 2004

Article Tools

* Image Usage & Resolution